Cargando…
Danish Prostate Cancer Consortium Study 1 (DPCC-1) protocol: Multicentre prospective validation of the urine-based three-microRNA biomarker model uCaP
INTRODUCTION: The primary objective of the Danish Prostate Cancer Consortium Study 1 (DPCC-1) is to provide validation for a novel urine-based microRNA biomarker, called uCaP, for a diagnosis of prostate cancer. METHODS AND ANALYSIS: Eligible participants are biopsy naïve men aged ≥18 years with pro...
Autores principales: | Fredsøe, Jacob, Glud, Eske, Boesen, Lars, Løgager, Vibeke, Poulsen, Mads Hvid, Pedersen, Bodil Ginnerup, Borre, Michael, Sørensen, Karina Dalsgaard |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10632827/ https://www.ncbi.nlm.nih.gov/pubmed/37940151 http://dx.doi.org/10.1136/bmjopen-2023-077020 |
Ejemplares similares
-
Predicting Grade group 2 or higher cancer at prostate biopsy by 4Kscore in blood and uCaP microRNA model in urine
por: Fredsøe, Jacob, et al.
Publicado: (2022) -
Cost-Effectiveness Analysis of Stockholm 3 Testing Compared to PSA as the Primary Blood Test in the Prostate Cancer Diagnostic Pathway: A Decision Tree Approach
por: Risør, Bettina Wulff, et al.
Publicado: (2022) -
Potential synergy between PSMA uptake and tumour blood flow for prediction of human prostate cancer aggressiveness
por: Jochumsen, Mads Ryø, et al.
Publicado: (2021) -
UCAP: A Framework for Accelerator Controls Data Processing @ CERN
por: Cseppentő, Lajos, et al.
Publicado: (2022) -
Prostate Cancer Detection Rate of Manually Operated and Robot-assisted In-bore Magnetic Resonance Imaging Targeted Biopsy
por: Sandahl, Mads, et al.
Publicado: (2022)